Krsnaa Diagnostics Limited has disclosed that it has received income tax assessment orders and demand notices amounting to Rs. 11,30,54,699 for the assessment years 2018-19 and 2019-20. The orders were issued by the Assistant Commissioner of Income Tax, Pune, under section 144 read with Section 147 and demand notices under Section 156 of the Income Tax Act, 1961.

The disclosure follows a search conducted by Income Tax Authorities on the company's premises under section 132 of the Income Tax Act, which was previously intimated on July 29, 2022. The company noted that the matter was being handled by external tax consultants, and the requirement for disclosure was identified during a subsequent internal compliance review.

Details of the Demand

The annexure provided to the exchanges details the specific financial implications of the orders. The aggregate demand is split between the two assessment years, comprising both tax and interest components.

The due date for payment is 30 days from the date of service of the demand notice, as per Section 156 of the Income Tax Act.

Company Response and Impact

Krsnaa Diagnostics has confirmed that it has already challenged the orders before the appropriate appellate and judicial forums. Management expressed confidence in defending the matter based on the facts and merits of the case.

Regarding the financial impact, the company stated that the demand represents an aggregate contingent liability of Rs. 11,30,54,699/-. Provisioning under Ind AS 37 is currently being evaluated. The company further clarified that there is no operational disruption resulting from these proceedings.

Krsnaa Diagnostics has announced comprehensive leadership changes following its board meeting held on April 17, 2026. The diagnostic services company has approved significant appointments and restructuring measures as part of strengthening its governance framework.

New Director Appointments

The board has approved the appointment of two new independent directors and re-appointment of one existing director, subject to member approval through postal ballot. These strategic appointments bring enhanced expertise to the company's leadership structure.

Mr. Raju Venkatraman brings extensive experience as a serial entrepreneur in diagnostics, healthcare, and IT sectors. He is the founder and former Chairman of Medall Healthcare Private Limited. Ms. Lilian Jessie Paul contributes over 25 years of marketing and corporate strategy expertise, currently serving on boards of PB Fintech and CreditAccess Grameen.

CFO Appointment and Leadership Transitions

The company has formalized the appointment of Chandra Prakash Singh as Interim Chief Financial Officer, designated as Key Managerial Personnel effective April 17, 2026. Singh will discharge CFO duties until a permanent appointment is made.

Singh brings over 28 years of finance experience across pharmaceuticals, FMCG, real estate, and consultancy sectors. He previously served as CFO at Brinton Pharmaceuticals Limited and holds qualifications as a Cost Accountant with CFO Program completion from IIM Calcutta.

Comprehensive Committee Restructuring

Following the director appointments, the board has approved comprehensive committee restructuring effective April 25, 2026. The reconstituted committees ensure enhanced governance and oversight capabilities across all key areas.

The board meeting, which commenced at 12:00 hours and concluded at 15:50 hours, demonstrates the company's commitment to strengthening its governance framework while ensuring continuity in operations during leadership transitions. The board has placed on record its appreciation for the valuable contributions of directors completing their tenure.